Candel Therapeutics
CADL
CADL
82 hedge funds and large institutions have $120M invested in Candel Therapeutics in 2025 Q1 according to their latest regulatory filings, with 24 funds opening new positions, 39 increasing their positions, 11 reducing their positions, and 12 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more first-time investments, than exits
New positions opened: | Existing positions closed:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more funds holding
Funds holding: →
2.6% more ownership
Funds ownership: 42.26% → 44.86% (+2.6%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
23% less capital invested
Capital invested by funds: $156M → $120M (-$36M)
Holders
82
Holding in Top 10
2
Calls
$4.4M
Puts
$2.65M
Top Buyers
| 1 | +$17.9M | |
| 2 | +$3.28M | |
| 3 | +$2.24M | |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$1.33M |
| 5 |
Geode Capital Management
Boston,
Massachusetts
|
+$1.31M |
Top Sellers
| 1 | -$13.9M | |
| 2 | -$3.08M | |
| 3 | -$1.59M | |
| 4 |
BCM
Bridgeway Capital Management
Houston,
Texas
|
-$670K |
| 5 |
MS
Maven Securities
St Helier,
Jersey
|
-$449K |
